The Office of Inspector General of the Department of Health and Human Services (“OIG”) released a proposed rule to eliminate safe harbor protection under the anti-kickback statute for drug price reductions that pharmaceutical manufacturers pay to Medicare and Medicaid plan sponsors and their pharmacy benefit managers (“PBMs”). The OIG proposed replacing the current safe harbor...
On October 18, 2018, the Centers for Medicare and Medicaid Services (“CMS”) proposed a new rule (“Proposal”) that would require direct-to-consumer (“DTC”) television advertisements of prescription drugs paid for by Medicare or Medicaid to include the drug’s wholesale acquisition cost (“List Price”). The Proposal comes as part of the current administration’s promise and attempt to...
Alissa SmithAlissa represents health systems, hospitals, pharmacies, long-term care providers, home he...
Andrew BrantinghamAndrew's experience spans a wide range of industries, and has particular depth in...
Rebecca BrommelBecki assists clients in the areas of litigation and administrative law wit...
Lillie CoxLILLIE ASSISTS A WIDE ARRAY OF HEALTHCARE INDUSTRY CLIENTS WITH CORPORATE TRANSACT...
Ross C. D'EmanueleRoss works in the health care provider, payor, and drug and medical device segment...
Nathan EbnetAs an associate in Dorsey's trial group, Nate Ebnet helps clients achieve their g...
Katie Ervin CarlsonKatie helps employers make day-to-day decisions that are legally sound and that re...
Randall HansonRandall is an associate in Dorsey’s health transactions and regulations practice group.
Alan IversonAlan is a litigator in Dorsey’s trial group with a focus on clients in...
Mackenzie McNaughtonWith experience in a broad range of tax issues, Mackenzie is able to pro...
Neal N. PetersonNeal regularly advises clients regarding compliance with laws specific to the he...
Vanessa J. SzalapskiAs an associate in the Trial Group, Vanessa serves clients in both federal and s...
